viernes, 20 de enero de 2017

Cancer Information Highlights, January 18, 2017

Cancer Information Highlights, January 18, 2017

National Cancer Institute

New from NCI
Facebook Live Event about Cervical Cancer Treatment
January Facebook Live Event Thursday, January 26, 2017 at 2:00 p.m.

NCI's Dr. Christina Annunziata and Dr. Sarah Temkin from Virginia Commonwealth University will discuss cervical cancer treatment and clinical trials.  
For Some Breast Cancer Survivors, Drug May Reduce Treatment-Related Joint Pain
clinician’s hand holding patient’s hand Results of a randomized clinical trial show that a drug most commonly used to treat depression may also reduce joint pain caused by drugs used to prevent breast cancer from returning.
Relief for Chronic Graft-Versus-Host Disease Symptoms

A small clinical trial shows that ibrutinib can treat symptoms of chronic graft-versus-host disease. Ibrutinib is a targeted cancer therapy.
Mammogram Fact Sheet

We’ve updated this fact sheet to include the latest information about factors related to false-positive test results, categories of breast density that require reporting, and two new research studies.
Drug Information Updates
New Drug for Ovarian Cancer

We've added a new drug summary for rucaparib camsylate. It was recently approved by the Food and Drug Administration (FDA) to treat advanced ovarian cancer with BRCA1 or BRCA2 gene mutations in patients who have already been treated with chemotherapy.
Also of Interest
Hair Dyes and Cancer Risk

This fact sheet reviews the research on a possible link between personal hair dye use and cancer.
Drugs Approved for Cervical Cancer

This page lists cancer drugs that the FDA has approved to treat cervical cancer.
Find NCI-Supported Clinical Trials

Find an NCI-supported clinical trial and learn how to locate other research studies that may be right for you or a loved one.
Cancer Information Highlights, January 18, 2017

No hay comentarios:

Publicar un comentario